![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Velpandian Thirumurthy
Publisher: Adis International
ISSN: 1174-5886
Source: Drugs in R&D, Vol.10, Iss.2, 2010-07, pp. : 93-96
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
`Doom and gloom' for neuroprotectants in stroke?
Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inpharma, Vol. 1, Iss. 1618, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prevention of Schizophrenia: Can it Be Achieved?
By Cheng Lee Thomas H. McGlashan Scott W. Woods
CNS Drugs, Vol. 19, Iss. 3, 2005-01 ,pp. :